|
|
|
|
|
|
Onconova Therapeutic (ONTX)
|
|
2.45 0 (+0.00%)
|
10/20/2017 4:00pm
|
|
Open:
|
2.47
|
Pre. Close:
|
2.45
|
|
High:
|
2.47
|
Low:
|
2.25
|
|
Volume:
|
114,687
|
Market Cap:
|
24.13M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
2.51 - 2.57
|
2.57 - 2.66
|
|
Low:
|
2.15 - 2.18
|
2.18 - 2.23
|
|
Close:
|
2.39 - 2.45
|
2.45 - 2.56
|
|
|
|
|
|
|
Technical analysis (as of: 2017-10-20 4:38:49 PM)
|
|
Overall:
|
|
|
Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.
|
|
Target:
|
Six months: 3.31 One year: 3.86
|
|
Support:
|
Support1: 1.98 Support2: 1.46
|
|
Resistance:
|
Resistance1:
2.83 Resistance2: 3.31
|
|
Pivot:
|
2.24 
|
|
Moving Averages:
|
MA(5): 2.51  MA(20): 2.12
MA(100): 1.94 MA(250): 2.33
|
|
MACD:
|
MACD(12,26):
0.22 Signal(12,26,9): 0.19
|
|
%K %D:
|
%K(14,3): 73.56 %D(3): 76.09
|
|
RSI:
|
RSI(14): 65.43
|
|
52-Week:
|
High: 3.88
Low: 1.46 Change(%): -3.5
|
|
Average Vol(K):
|
3-Month: 14613
10-Days 61434
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.ONTX has closed below upper band by 36.8%. Bollinger Bands are 298.6% wider than normal. The large width of the bands suggest high volatility as compared to ONTX's normal range. The bands have been in this wide range for 9 bars. This is a sign that the current trend might continue.
|
|
|
Headline News
|
|
Fri, 27 Jan 2017 13:30:00 GMT
Onconova Therapeutics, Inc. to Present at NobleCON13
Tue, 04 Apr 2017 13:08:56 GMT
Onconova Therapeutics stock surges 18% on positive pre-clinical data for ...
Thu, 09 Feb 2017 13:30:00 GMT
Onconova Therapeutics, Inc. to Present at Two Investor Conferences in February
Thu, 16 Mar 2017 12:22:30 GMT
Onconova Therapeutics, Inc. to Provide Corporate Update and Full Year 2016 ...
Mon, 05 Jun 2017 12:50:38 GMT
UPDATE: Onconova Therapeutics stock surges 7% on positive mid-stage clinical ...
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
